CNApp, a tool for the quantification of copy number alterations and integrative analysis revealing clinical implications
- Institut D'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic de Barcelona, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Universitat de Barcelona, Spain
- Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Spain
Abstract
Somatic copy number alterations (CNAs) are a hallmark of cancer, but their role in tumorigenesis and clinical relevance remain largely unclear. Here we developed CNApp, a web-based tool that allows a comprehensive exploration of CNAs by using purity-corrected segmented data from multiple genomic platforms. CNApp generates genome-wide profiles, computes CNA scores for broad, focal and global CNA burdens, and uses machine learning-based predictions to classify samples. We applied CNApp to the TCGA pan-cancer dataset of 10,635 genomes showing that CNAs classify cancer types according to their tissue-of-origin, and that each cancer type shows specific ranges of broad and focal CNA scores. Moreover, CNApp reproduces recurrent CNAs in hepatocellular carcinoma, and predicts colon cancer molecular subtypes and microsatellite instability based on broad CNA scores and discrete genomic imbalances. In summary, CNApp facilitates CNA-driven research by providing a unique framework to identify relevant clinical implications. CNApp is hosted at https://tools.idibaps.org/CNApp/.
Data availability
Data and plots presented in the submission were generated by using our CNApp tool. Source code and additional files can be found at GitHub (https://github.com/ait5/CNApp).
Article and author information
Author details
Sebastià Franch-Expósito
Funding
CIBEREHD
- Sebastià Franch-Expósito
Fundacion Cientifica de la Asociacion Espanola Contra el Cancer (GCB13131592CAST)
- Juan José Lozano
- Antoni Castells
- Sergi Castellvi-Bel
- Jordi Camps
European Commission /Horizon 2020 Program (HEPCAR Ref. 667273-2)
- Josep Maria Llovet
U.S. Department of Defense (CA150272P3)
- Josep Maria Llovet
National Cancer Institute (P30-CA196521)
- Josep Maria Llovet
Samuel Waxman Cancer Research Foundation
- Josep Maria Llovet
Spanish National Health Institute (SAF2016-76390)
- Josep Maria Llovet
Generalitat de Catalunya/AGAUR (SGR-1162)
- Josep Maria Llovet
Generalitat de Catalunya/AGAUR (SGR-1358)
- Josep Maria Llovet
European Regional Development Fund (PI14/00783)
- Marcos Díaz-Gay
- Juan José Lozano
- Antoni Castells
- Sergi Castellvi-Bel
- Jordi Camps
European Regional Development Fund (PI17/01304)
- Marcos Díaz-Gay
- Juan José Lozano
- Antoni Castells
- Sergi Castellvi-Bel
- Jordi Camps
Generalitat de Catalunya (AGAUR 2016BP00161)
- Laia Bassaganyas
European Regional Development Fund (PI17/00878)
- Marcos Díaz-Gay
- Juan José Lozano
- Antoni Castells
- Sergi Castellvi-Bel
- Jordi Camps
Generalitat de Catalunya (2017 SGR 21)
- Juan José Lozano
- Antoni Castells
- Sergi Castellvi-Bel
- Jordi Camps
Generalitat de Catalunya (2017 SGR 653)
- Juan José Lozano
- Antoni Castells
- Sergi Castellvi-Bel
- Jordi Camps
Generalitat de Catalunya (AGAUR 2018FI B1_00213)
- Marcos Díaz-Gay
Spanish National Health Institute (FPI BES-2017-081286)
- Roger Esteban-Fabró
European Comission (PCIG11-GA-2012-321937)
- Juan José Lozano
- Antoni Castells
- Sergi Castellvi-Bel
- Jordi Camps
European Regional Development Fund (CP13/00160)
- Marcos Díaz-Gay
- Juan José Lozano
- Antoni Castells
- Sergi Castellvi-Bel
- Jordi Camps
CERCA Program
- Juan José Lozano
- Antoni Castells
- Josep Maria Llovet
- Sergi Castellvi-Bel
- Jordi Camps
Generalitat de Catalunya (2017 SGR 1035)
- Juan José Lozano
- Antoni Castells
- Sergi Castellvi-Bel
- Jordi Camps
PERIS Generalitat de Catalunya (SLT002/16/00398)
- Juan José Lozano
- Antoni Castells
- Sergi Castellvi-Bel
- Jordi Camps
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Copyright
© 2020, Franch-Expósito et al.
This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 9,786
- views
-
- 497
- downloads
-
- 50
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
CNApp, a tool for the quantification of copy number alterations and integrative analysis revealing clinical implications
eLife 9:e50267.
https://doi.org/10.7554/eLife.50267
Further reading
-
- Computational and Systems Biology
Degree distributions in protein-protein interaction (PPI) networks are believed to follow a power law (PL). However, technical and study biases affect the experimental procedures for detecting PPIs. For instance, cancer-associated proteins have received disproportional attention. Moreover, bait proteins in large-scale experiments tend to have many false-positive interaction partners. Studying the degree distributions of thousands of PPI networks of controlled provenance, we address the question if PL distributions in observed PPI networks could be explained by these biases alone. Our findings are supported by mathematical models and extensive simulations, and indicate that study bias and technical bias suffice to produce the observed PL distribution. It is, hence, problematic to derive hypotheses about the topology of the true biological interactome from the PL distributions in observed PPI networks. Our study casts doubt on the use of the PL property of biological networks as a modeling assumption or quality criterion in network biology.
-
- Computational and Systems Biology
- Immunology and Inflammation
Transcription factor partners can cooperatively bind to DNA composite elements to augment gene transcription. Here, we report a novel protein-DNA binding screening pipeline, termed Spacing Preference Identification of Composite Elements (SPICE), that can systematically predict protein binding partners and DNA motif spacing preferences. Using SPICE, we successfully identified known composite elements, such as AP1-IRF composite elements (AICEs) and STAT5 tetramers, and also uncovered several novel binding partners, including JUN-IKZF1 composite elements. One such novel interaction was identified at CNS9, an upstream conserved noncoding region in the human IL10 gene, which harbors a non-canonical IKZF1 binding site. We confirmed the cooperative binding of JUN and IKZF1 and showed that the activity of an IL10-luciferase reporter construct in primary B and T cells depended on both this site and the AP1 binding site within this composite element. Overall, our findings reveal an unappreciated global association of IKZF1 and AP1 and establish SPICE as a valuable new pipeline for predicting novel transcription binding complexes.
